Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 15 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. Our success has been deeply rooted in our commitment to invest approximately 10% of our revenues into R&D every year. With more than 800 engineers on staff, we have built a world-class platform that capitalizes on low-cost China based R&D operations and a culture that is driven by ingenuity, and both individual and team performance. We currently offer more than 40 products across three product segments including patient monitoring devices, diagnostic laboratory instruments and ultrasound imaging systems. In 2006, along with our newly released BeneView T8, WATO-50, and DC-6, we released the BC-5500, the first five-part hematology analyzer developed by a Chinese company. In China, we have distributed products to approximately 27,000 hospitals, clinics, and healthcare facilities; and at the end of 2006 we had sold over 200,000 devices in over 140 countries worldwide. We began exporting our products for the first time in 2000; and in the second half of 2006, revenues generated from international markets exceeded domestic revenues for the first time in our operating history. Our Company&＃039;s American Depositary Shares (ADSs) are listed on the New York Stock Exchange (NYSE) under the symbol MR